|
![]() |
|||||
![]() |
Meetings |
|||||
October3rd Annual Genetic Variance. Oct. 1617, Philadelphia. For information, contact Cambridge Healthtech Institute, 1037 Chestnut St., Newton Upper Falls, MA 02464 (617-630-1300; fax 617-630-1325; chi@healthtech.com). Functional Genomics: From Genome to Function. Oct. 1617, Litchfield Park, AZ. For information, contact IBC USA, One Research Dr., Westborough, MA 01581 (508-616-5550; fax 508-616-5522; reg@ibcusa.com). Proteomics, Functional Genomics, and Bioinformatics. Oct. 1619, Litchfield Park, AZ. For information, contact IBC USA, One Research Dr., Westborough, MA 01581 (508-616-5550; fax 508-616-5522; reg@ibcusa.com). Proteomics: Rapid Target Identification & Validation. Oct. 1617, Litchfield Park, AZ. For information, contact IBC USA, One Research Dr., Westborough, MA 01581 (508-616-5550; fax 508-616-5522; reg@ibcusa.com).
NovemberIntroduction to Food Law and Regulation. Nov. 23, Arlington, VA. For information, contact FDLI, 1000 Vermont Ave., NW, Ste. 200, Washington, DC 20005 (202-371-1420; fax 202-371-0469; Comments@FDLI.org). Partnering in Drug Discovery. Nov. 68, La Jolla, CA. For information, contact IBC USA, One Research Dr., Westborough, MA 01581 (508-616-5550; fax 508-616-5522; reg@ibcusa.com). Pharmaceutical Process Development. Nov. 68, New Brunswick, NJ. For information, contact the Center for Professional Advancement, Box 1052, 144 Tices La., East Brunswick, NJ 08816-1052 (732-238-1600; fax 732-238-9113; info@cfpa.com; www.cfpa.com). Future Strategies for Drug Discovery and Development. Nov. 1315, Boston. For information, contact Cambridge Healthtech Institute, 1037 Chestnut St., Newton Upper Falls, MA 02464 (617-630-1300; fax 617-630-1325; chi@healthtech.com). Agbiotech 2000: Innovation in Asia. Nov. 1518, Singapore. For information, contact Nature Biotechnology, 345 Park Ave. South, New York, NY 10010-1707 (212-726-9335; fax 212-696-9635; biotech@natureny.com).
December7th Annual Ottawa Life Sciences National Conference and Exhibition: The BioProducts Revolution. Dec. 46, Ottawa. For information, contact Ottawa Life Sciences Council, 600 Peter Morand Cres., Ste. 100, Ottawa, Ont. K1G 5Z3 (613-521-4878; fax 613-521-3065; info@olsc.ca). Preparing Clinical Protocols and Managing Clinical Investigations. Dec. 78, New Brunswick, NJ. For information, contact the Center for Professional Advancement, Box 1052, 144 Tices La., East Brunswick, NJ 08816-1052 (732-238-1600; fax 732-238-9113; info@cfpa.com; www.cfpa.com). E-Healthcare. Dec. 1314, London. For information, contact SMi Group, 1 New Concordia Wharf, Mill St., London SE1 2BB England (44 (0)207 827 6000; fax 44 (0)207 827 6001). Good Laboratory Practice. Dec. 1415, Toronto. For information, contact Pharmalinx, Ste. 209, 5807-104 St., Edmonton, Alberta T6H 2K4, Canada (780-437-8140; fax 780-432-1920; pharmalinx@pharmalinx.net). Assessing Clinical Efficacy of Cardiovascular Drugs. Dec. 2122, Paris. For information, contact the Drug Information Association, 501 Office Center Dr., Ste. 450, Fort Washington, PA 19034 (215-628-2288; fax 215-641-1299; www.diahome.org).
January 2001The Role of R&D in Strategic Partnering. Jan. 89, Baltimore. For information, contact the Drug Information Association, 501 Office Center Dr., Ste. 450, Fort Washington, PA 19034 (215-628-2288; fax 215-641-1299; www.diahome.org). Building Bridges Between the Regulators and Pharmaceutical Industry . . . Developing Countries Entering the Millennium. Jan. 911, Lahore, Pakistan. For information, contact the Drug Information Association, 501 Office Center Dr., Ste. 450, Fort Washington, PA 19034 (215-628-2288; fax 215-641-1299; www.diahome.org). Clinical Trials Design. Jan. 1819, Las Vegas. For information, contact Clinical Design Group, Inc., 2128 W. Evergreen Ave., Chicago, IL 60622 (773-489-5706; fax 773-489-5981). Antibody Production and Downstream Processing: Creating Successful Antibody-Based Biopharmaceutical Products. Jan. 31Feb. 2. San Diego. For information, contact IBC, One Research Dr., Westborough, MA 01581 (508-616-5550; fax 508-616-5522; reg@ibcusa.com). |